Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
9,519
Total Claims
$1.4M
Drug Cost
962
Beneficiaries
$1,427
Cost/Patient
Risk Score Breakdown 14/100
Score components are additive. Read full methodology
Peer Comparison vs. 110,156 Internal Medicine providers
-7%
Opioid rate vs peers
2.1% vs 2.2% avg
+1%
Cost per patient vs peers
$1,427 vs $1,411 avg
+36%
Brand preference vs peers
14.4% vs 10.6% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
Opioid Prescribing
2.1%
Opioid Rate
198
Opioid Claims
$21K
Opioid Cost
19.2%
Long-Acting Rate
Brand vs Generic
Brand: 1,359 claims · $1.1M
Generic: 8,048 claims · $234K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Semaglutide | 164 | $181K |
| Apixaban | 118 | $147K |
| Empagliflozin | 96 | $135K |
| Rivaroxaban | 60 | $84K |
| Sitagliptin Phosphate | 63 | $82K |
| Insulin Glargine,hum.Rec.Anlog | 88 | $77K |
| Semaglutide | 17 | $37K |
| Dulaglutide | 12 | $30K |
| Sitagliptin Phos/Metformin Hcl | 15 | $24K |
| Linagliptin | 11 | $19K |
| Tirzepatide | 14 | $17K |
| Insulin Detemir | 17 | $16K |
| Budesonide/Formoterol Fumarate | 23 | $15K |
| Fluticasone/Vilanterol | 27 | $14K |
| Oxycodone Hcl | 15 | $12K |
Prescribing Profile
Patient Profile
75
Avg Age
43%
Female
1.37
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About